banner

MMRGlobal CEO Bob Lorsch Featured on BravoTV’s “Interior Therapy”

Interior Therapy with Jeff Lewis Lorsch Episode

Last Wednesday, March 21, 2012, the BravoTV show “Interior Therapy with Jeff Lewis” featured a renovation of the home of MMRGlobal, Inc. (OTCBB:MMRF) Chief Executive Officer Robert Lorsch.  At OTC Showcase, we have followed and written on MMRGlobal and its chief for a number of years pertaining to corporate developments as well as the backdrop of stories surrounding Lorsch, including his philanthropic efforts with the Wildlife WayStation in California (and subsequent battle with the United States Department of Agriculture) and ongoing litigation with Real Housewives of Beverly Hills star Taylor Armstrong for her involvements in the then privately-held MyMedicalRecords.com.


The airing of the television show on Wednesday prompted a phone call to Lorsch later in the week in which we discussed several topics about why he chose to do the show and what impact he believes it may have on awareness for MMRGlobal.  Aside from the stock market component, it is hard to overlook the fact that BravoTV – the station that made “Taylor Armstrong” a household name before Lorsch’s lawsuit against Taylor and her now-deceased husband hit the mainstream public exposing their less-than-scrupulous business activities – aired a show on Lorsch that showcased the softer side of the businessman and gave a bit of insight as to all the charities he has been involved with over the last four decades.

We asked Bob what inspired the feature on the show.  He explained that Bravo brought his wife (and MyMedicalRecords.com spokesperson), Kira Lorsch, in to meet on another project and then came back and offered to meet the Lorsch’s for the episode on “Interior Therapy”.  Kira and Bob liked the idea because of a charity component that could help to encourage people to give things to charity, something that they both clearly believe strongly in.

MMRGlobal (MMRF)

According to both the Lorsch’s, the response to the show has been overwhelming.  “We have received more than a thousand letters, proposals and emails from people already.  It’s very gratifying from my position as CEO of MMRF because many of those people have commented that they were not aware of MMRGlobal and MyMedicalRecords.com before.  One of the first people that recognized me on the street after the show aired was a woman who has spent the last 30 years as a private wealth manager with Merrill Lynch.   She told me about the impact the show had on her and that she was looking further into MMRF.”

Bob’s passion for endeavors that he enters into is pretty obvious and one thing that sets him apart from many other senior executives in the OTC stock world.  While his totally-committed attitude always rings true for either a charity or a business, Lorsch made it very clear that there is major distinction between the two.  “I always go ‘all-in’.   I’ve never wanted to be average – in fact, being average scares the hell out of me – and use that as a driving force in everything that I do.  But, make no mistake about it, MMRGlobal is not a charity.  It’s a business and I intend to make this the most successful business story of my life.  I feel strongly that people should always give back and that’s why I am so involved with charities, but at the heart of things, I am a capitalist.  I have a deep commitment to the shareholders of MMRF and all of those that believe in me to see this company through to profitability.  That’s what I intend to do.”

We couldn’t leave the conversation without asking about the status of the lawsuit against Armstrong.  “All I can say publicly is that the attorneys on the two sides are talking and I would hope to provide an update in the near term.  We’ll have to leave it at that for now,” said Lorsch.

BravoTV will be re-running the episode of “Interior Therapy with Jeff Lewis” titled “Charity Starts at Home,” on several occasions.  It is also available for download on iTunes and Amazon.  Hulu does not have rights to the show at this time.

MMRGlobal (MMRF) Stock Quote and News:







Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Stocks Mixed on Monday

Stocks Mixed on Monday(0)

The Dow Jones industrial average topped 16,000 for the first time ever Monday, while the S&P 500 briefly surpassed 1,800. The Dow retreated from the 16,000 level, but still gained 14.32 points from Friday”s all-time high close, to 15,976. The S&P 500 index dipped 6.65 points to 1,791.53. The NASDAQ fell 36.90 points to 3,949.07

Cellceutix Targeting Gram-Negative and Candida Fungal Infections

Cellceutix Targeting Gram-Negative and Candida Fungal Infections(0)

Monday morning, Cellceutix Corp. (OTCQB: CTIX) provided shareholders with an update on its progress with filing an Investigational New Drug application with the FDA for its anti-psoriasis drug. Additionally – and taking the headline – the company delivered to shareholders news that it has made additional promising advancements with its pipeline to potentially address diseases

Catalyst Pharmaceutical Partners Stock Chart Analysis Video

Catalyst Pharmaceutical Partners Stock Chart Analysis Video(0)

The Catalyst Pharmaceutical Partners (NASDAQ: CPRX) stock chart formed a piercing line reversal pattern on Wednesday and Thursday that was confirmed with a sharp move upwards on Friday. Technical traders will be watching support around the 200 day moving average at $1.25 on any pullback, but for the time being, the chart looks to be

EnteroMedics Stock Chart Analysis Video

EnteroMedics Stock Chart Analysis Video(0)

The EnteroMedics (NASDAQ:ETRM) chart has been making higher highs and higher lows since forming a double bottom early in the year. The chart is holding over the 50-day moving average and inching higher each day as it tries to gain momentum to make the next leg up in the channel. EnteroMedics is a medical device

NXT-ID Authentication Using Face and Voice Recognition

NXT-ID Authentication Using Face and Voice Recognition(0)

There’s a Wocket in My Pocket! may soon not just be a sentence from the mouths of children after reading the rhyming book by Dr. Seuss. There was plenty of made-up ridiculousness in the iconic book, such as a bofa on the sofa, but there is nothing fictitious about the Wocket, a next-generation payment and

read more
banner

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.